Home Wealth  Money Cell Therapeutics Says Panel Confirms Study Robustness

Cell Therapeutics Says Panel Confirms Study Robustness

Posted: Sep. 29th, 2011  |  By Forbes

powered by Forbes

RSS Syndicated News Email a Friend Suggest an Article Share Visit Website

Cell Therapeutics shares are getting a boost today after the company announced that a second independent radiology assessment of data from a clinical trial of the companys antitumor treatment pixantrone confirmed the statistical robustness of the data.

The response and progression endpoint data was previously submitted to the US Food and Drug Administration with the new drug application for pixantrone.

The second assessment was recommended by the FDAs Office of New Drugs as part of Cell Therapeutics (nasdaq: CTIC - news - people ) appeal to the complete response letter it had previously received from the FDA.

The company said it plans on resubmitting the drug as early as next month for accelerated approval, which could provide an FDA action date by April 2012.

Cell Therapeutics had announced earlier in the week that a UnitedHealth Group (nyse: UNH - news - people ) executive, Reed Tuckson, has joined its board.

This year, the company has licensed rights from Chroma Therapeutics to develop tosedostat, and it has an ongoing relationship with Novartis (nyse: NVS - news - people ) for the licensing of Opaxio.

Market News Video produces and distributes online videos about stocks and investing.

Share on Facebook Share
See Next Article
Need to Get Away?
Top 10 Business Hotels
Who says you can’t mix business with pleasure?
Read More
More Articles from Forbes.com

Quick Links
Real Estate
Luxury Travel
Search Real Estate
Find Your Dream Home
Search for homes by
State, Country or Style.
Event Calendar
Current News & Features
The 2016 Campari Calendar’s Bitter vs. Sweet Debate is On! Which Kate Hudson Do You Stand With?
LA Auto Show Drops the Curtain for the Mercedes-Benz SL and GLS Roadster
Drink in Style Over the Holidays With the $9k Limited-Edition FACUNDO Luxury Bar Cart
Artist Sophie Kipner On the Unique Intimacy of Drawing Without Looking
Gucci's First Full-Service Restaurant Quietly Opens Above Boutique in Shanghai Mall
Secure One of Cobalt's First Ultra Private Jet With a $15k Deposit
Star-Studded Los Cabos Film Festival Combines Film and Adventure in 4th Year
Bring Out Your Inner Child With This Miniature Remote-Controlled Lexus RC F Sport Coupe
Add This Black Quinoa-Stuffed Acorn Squash Dish to Your Repertoire
Dazzle Holiday Guests With the World’s Most Glamorous $947k Christmas Tree Star
See the complete list
Featured Photo Gallery
See the complete list